Michael McKenney
Analyst · Chris Howe from Barrington Research
Thank you, Jeff. I'll start with some key financial metrics from our fourth quarter, which included some notable records. Consolidated gross margins were 42.4% in the fourth quarter of 2021 compared to 44.1% in the fourth quarter of 2020, down 170 basis points. Our consolidated gross margins in the fourth quarter of 2021 were negatively affected by the amortization of acquired profit and inventory related to the Clouth and Balemaster acquisitions, which lowered consolidated gross margins by 90 basis points. In the fourth quarter of 2020, government assistance benefits increased consolidated gross margins by 50 basis points. Excluding the impact from both these items, consolidated gross margins were down 30 basis points due to a higher mix of capital revenue. Our overall percentage of parts and consumables revenue decreased to 63% of total revenue in the fourth quarter 2021 compared to 67% in the fourth quarter of 2020 due to a significantly higher capital revenue at our Industrial Processing segment. SG&A expenses were $57.8 million in the fourth quarter of 2021 and increased -- an increase of $10.4 million compared to $47.4 million in the fourth quarter of 2020. Fourth quarter of 2021, SG&A includes $6.4 million in SG&A from our acquisitions and an increase of $1.5 million in acquisition-related costs, which totaled $1.7 million in the fourth quarter 2021 compared to $0.2 million in the prior year. The remaining increase in SG&A expense is primarily associated with increased incentive compensation due to improved business conditions. As a percentage of revenue, SG&A expenses decreased to 26.4% in the fourth quarter of 2021 compared to 28.1% in the prior year period. For the first time in our history, our quarterly GAAP diluted EPS exceeded $2, reaching $2.07 in the fourth quarter 2021 compared to $1.40 in the fourth quarter of 2020. Our GAAP diluted EPS in the fourth quarter includes $0.23 in acquisition-related costs, $0.08 of restructuring costs, a $0.04 discrete tax benefit and a $0.03 gain on the sale of the building. $0.23 in acquisition-related costs includes $0.13 of amortization of acquired profit in inventory, $0.04 of backlog amortization and $0.06 of acquisition costs. The amortization of acquired profit in inventory related to the 2021 acquisition has been completed, and there is a $0.7 million or $0.05 of backlog amortization remaining, which will turn in 2022. The $0.08 in restructuring costs includes an asset impairment charge and other costs associated with the consolidation of our ceramic blade manufacturing in Europe into our recently acquired Clouth business. Tax rate in the fourth quarter was 19.5% and included approximately $0.16 of tax benefits related to a reversal of tax reserves associated with uncertain tax positions and the exercise of previously awarded employee stock options. Excluding these items, our tax rate would have been 25.9%. For the full year, 2021 gross margins were 42.9% compared to 43.7% in 2020. Excluding the amortization of profit and inventory, which reduced 2021 gross margins by 50 basis points and government assistance benefits in both periods, gross margins were up 20 basis points to 43.3% compared to 43.1%. Our percentage of parts and consumables revenue was 65% in 2021 compared to 66% in 2020. SG&A expenses were $208.8 million in 2021, an increase of $26.9 million or 15% compared to $181.9 million in 2020. As a percentage of revenue, SG&A expenses decreased to 26.5% in 2021 compared to 28.6% in 2020. We had $9.7 million of SG&A from our acquisitions in 2021 and incurred acquisition-related costs of $5 million and $1 million in 2021 and 2020, respectively. In addition, there was an unfavorable foreign currency translation effect of $5.1 million in 2021, and we had a reduction in government assistance benefits of $0.8 million. Excluding all these items, SG&A expenses were up $7.3 million or 4% compared to 2020, primarily due to an increase in incentive compensation. Our GAAP diluted EPS was a record $7.21 in 2021, up 51% compared to $4.77 in 2020. Our GAAP diluted EPS in 2021 includes $0.60 in acquisition-related costs, $0.08 of restructuring costs, a $0.04 benefit from discrete tax items and a $0.03 gain on the sale of the building. In addition, our 2021 results included pretax income of $2.4 million or $0.16 net of tax attributable to government employee retention assistance programs related to the pandemic compared to pretax income of $6.1 million or $0.39 net of tax in 2020. In the fourth quarter of 2021, adjusted EBITDA increased 39% to a record $44.8 million or 20.5% of revenue compared to $32.1 million or 19.1% of revenue in the fourth quarter of 2020 due to strong performance in our Industrial Processing segment, led by our wood processing product line. For the full year, adjusted EBITDA was a record $159.4 million or 20.3% of revenue compared to 2020 adjusted EBITDA of $115.9 million or 18.3% of revenue. Our operating and free cash flow performance was exceptional and demonstrates our continued strength in generating excellent cash flows from operations around the world. Operating cash flows was a record $61 million in the fourth quarter of 2021, far exceeding our prior quarterly record of $44.4 million. For the full year, operating cash flow was a record $162.4 million, up 75% from 2020 and up 67% compared to our prior record set in 2019. Free cash flow was $55.9 million in the fourth quarter of 2021, increasing 47% compared to the fourth quarter of 2020. For the full year, free cash flow was $149.6 million, up 75% from 2020 and 71% compared to our prior record set in 2019 of $87.5 million. We had several notable non-operating uses of cash in the fourth quarter of 2021. We repaid $42.5 million of debt, paid $5.1 million for capital expenditures and paid a $2.9 million dividend on our common stock. We also paid $2.9 million for the acquisition of a small stock preparation manufacturer in India. For the full year, we paid $144 million for acquisitions, net of cash acquired, and repaid $104 million of our debt. Let me turn to our EPS results for the quarter. In the fourth quarter 2021, GAAP diluted earnings per share was $2.07, and adjusted diluted EPS was $2.31. In the fourth quarter of 2020, GAAP diluted earnings per share was $1.40 and adjusted diluted EPS was $1.54. The $0.14 difference relates to an intangible asset impairment charge of $0.12, restructuring costs of $0.01 and amortization of acquired backlog of $0.01. The increase of $0.77 in adjusted diluted EPS in the fourth quarter of 2021 compared to the fourth quarter of 2020 consists of the following; $0.91 due to higher revenue, $0.11 from acquisitions and $0.04 due to lower interest expense. These increases were partially offset by $0.13 due to higher operating expenses, $0.08 due to government assistance programs received in the prior year, $0.05 due to lower gross margins, $0.02 due to higher weighted average shares outstanding and $0.01 due to a lower recurring tax rate. Collectively, included in all the categories I just mentioned was a favorable foreign currency translation effect of $0.03 in the fourth quarter of 2021 compared to last year's fourth quarter due to the weakening of the U.S. dollar. Now turning to our EPS results for the full year on Slide 17. We reported GAAP diluted earnings per share of $7.21 in 2021, and our adjusted diluted EPS was $7.83. We reported GAAP diluted earnings per share of $4.77 in 2020, and our adjusted diluted EPS was $5. The $0.23 difference relates to an intangible asset impairment charge of $0.12, restructuring costs of $0.07, amortization of acquired backlog of $0.04, acquisition costs of $0.03 and a discrete tax benefit of $0.03. The increase of $2.83 in adjusted diluted EPS from 2020 to 2021 consists of the following; $3.33 from higher revenue, $0.23 from lower interest expense, $0.21 from the operating results of our acquisitions, $0.12 from higher gross margins and $0.04 from a lower recurring tax rate. These increases were partially offset by $0.78 from higher operating expenses, $0.23 from a reduction in benefits from government assistance programs, $0.06 due to higher weighted average shares outstanding and $0.03 from higher non-controlling interest expense. Collectively, included in all the categories I just mentioned, was a favorable foreign currency translation effect of $0.33 in 2021 compared to 2020. Now let's turn to our liquidity metrics, starting on Slide 18. Cash conversion days measure, calculated by taking days in receivables plus days in inventory and subtracting days in accounts payable was 106 at the end of the fourth quarter of 2021, down from 113 at the end of the third quarter of 2021 and 125 days at the end of 2020. The decrease in cash conversion days from the prior year was principally driven by a higher number of days in accounts payable. Working capital as a percentage of revenue decreased to 9.4% in the fourth quarter of 2021 compared to 13.5% in the third quarter of 2021 and 14.2% in the fourth quarter of 2020. Net debt, that is debt less cash at the end of 2021 was $175.4 million, a decrease of $55 million sequentially and compares to $166.8 million at the end of 2020. Our interest expense decreased 35% or $2.6 million to $4.8 million in 2021 compared to $7.4 million in 2020. Our leverage ratio, calculated as defined in our credit agreement, was 1.34 at the end of the fourth quarter of 2021, down from 1.61% in the fourth quarter 2020. Quite an accomplishment given that we paid $144 million net of cash acquired for acquisitions in 2021. Now I'll review our guidance for 2022. Our revenue guidance for the first quarter of 2022 is $212 million to $217 million, and our adjusted diluted EPS guidance for the first quarter is $2 to $2.10. This excludes $0.05 from the amortization of acquired backlog. For the full year, our revenue guidance is $870 million to $890 million, and our adjusted diluted EPS guidance for the full year is $8.55 to $8.75 and excludes $0.05 from the amortization of acquired backlog. I should caution here that there could be some choppiness and variability in our quarterly results due to several factors, including the variability of order flow and the timing of capital shipments. In addition, other risks that could impact our guidance include supply chain challenges, strengthening of the U.S. dollar, geopolitical tensions and China's zero-COVID policy. The 2022 guidance includes an unfavorable foreign currency translation impact of approximately $12 million on revenue and $0.15 on adjusted diluted EPS due to the strengthening of the U.S. dollar. Excluding the amortization of profit and inventory and the benefit from government assistance programs, our gross margins came in at 43.3% in 2021. And we anticipate gross margins for 2022 will be close to this level at 43% to 43.5%. As a percentage of revenue, we anticipate SG&A will be approximately 25% to 25.5%, and R&D expense will be approximately 1.5% of revenue in 2022. We anticipate net interest expense of approximately $5.5 million to $5.8 million. And we expect our recurring tax rate will be approximately 28% in 2022. Our recurring tax rate in the first quarter of '22 may be a little lower than the remaining quarters, which we anticipate receiving a tax benefit from the vesting of equity awards. We expect depreciation and amortization will be approximately $36 million to $37 million in 2022. And we anticipate CapEx spending in 2022 will be approximately 2% of revenue. In addition to the CapEx guidance I just provided, I want to outline for you another project starting in 2022. In 2006, we acquired a business in China to help us grow our stock preparation product line. As many of you are aware, that business has performed very well. When we acquired the business, we acquired its manufacturing facility. At that time, the facility was in the commercial area. As the city in which this business is located is growing, the area around our facility has become more residential. As a result, the local government has asked us to relocate our manufacturing operations. We have been discussing and negotiating with the local government for several years. In the fourth quarter of 2021, we reached an agreement, which we believe is likely to become effective in the first quarter of 2022. The local government will buy our existing facility at an agreed-upon price. And over the next 2 years, we will build and move into a new facility in the same city. Proceeds from selling the facility will pay for the new facility and the relocation costs that will be incurred. Currently estimate the CapEx for this project to be approximately $20 million, with most of the CapEx costs being incurred over the next 18 months. To date, the local government has paid a 25% down payment on the agreed-to-sell price with an additional 6% payment anticipated in the first quarter of 2022. The remaining proceeds from the sale of the facility will be due at the earlier of when the government sells the property or within 2 years of the effective date of the agreement. The U.S. GAAP accounting for this will result in a large gain on the sale of our existing facility when the final down payment is received, and the agreement goes into effect. We anticipate this will be in the first quarter of 2022. When this occurs, I will give all the numbers related to this transaction and the gain will be excluded from our adjusted diluted EPS results. For U.S. GAAP purposes, the costs related to the new facility will be reflected in our CapEx numbers. I will also give color each quarter as we go forward on regular CapEx and CapEx related to this project. The key point I want folks to be aware of is that on a cash basis, at the end of the day, once we received all the proceeds from selling the old facility, the cost of the new facility will be offset by the proceeds received from the old facility sale. I also wanted to make it clear that our EPS and CapEx guidance for 2022 does not include this transaction. That concludes my review of the financials, and I will now turn the call back over to the operator for our Q&A session. Operator?